[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Lianxin Wang\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":44},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":23,"studyType":24,"phases":4,"briefSummary":25,"conditions":26,"keywords":28,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":4},"100606150","cohort-study-of-honghua-xiaoyao-tablets-in-the-treatment-of-premenstrual-syndrome-based-on-target-trial-emulation-framework-100606150",false,"NCT07171814","Cohort Study of Honghua Xiaoyao Tablets in the Treatment of Premenstrual Syndrome Based on Target Trial Emulation Framework","Cohort Study of Honghua Xiaoyao Tablet in the Treatment of Premenstrual Syndrome Based on Target Trial Emulation Framework","TTE","Inclusion Criteria:\n\n1. Age:18-40 years old (both ends included);\n2. According to the 8th edition of \"Obstetrics and Gynecology\" (2014), patients diagnosed with premenstrual syndrome;\n3. In accordance with the TCM syndrome differentiation standard of liver depression and qi stagnation.\n\nExclusion Criteria:\n\n1. those who were allergic to the ingredients and excipients of Honghua Xiaoyao tablet (exposure group);\n2. In the non-exposed group, those receiving or planning to receive other targeted medications for PMS, such as serotonin reuptake inhibitors (SSRIs), hormones, etc.;\n3. irregular menstrual cycle (menstrual cycle not within 28±7 days);\n4. serious diseases of cardiovascular, cerebrovascular, hematopoietic system, liver and kidney, and malignant tumors;\n5. pregnant or lactating women, or those who plan to become pregnant within 6 months;\n6. patients with mental illness and alcohol or drug dependence; Patients with other complicated lesions were not eligible for this study.","FEMALE","18 Years","40 Years",{"count":21,"type":22},266,"ESTIMATED","4 Months","OBSERVATIONAL","To evaluate the efficacy and safety of Honghua Xiaoyao tablets in the treatment of premenstrual syndrome, and the results were further analyzed and evaluated by target trial simulation (TTE) framework.",[27],"Premenstrual Syndrome",[29,30,31],"Honghua Xiaoyao tablet","Target trial emulation","The real world","NOT_YET_RECRUITING","2025-09-06",{"date":35,"type":36},"2025-09-15","ACTUAL",{"date":38,"type":22},"2025-09-30",{"date":40,"type":22},"2027-09-30",{"name":42,"class":43},"Lianxin Wang","OTHER",""]